PRAX compared with IDYA: revenue, margins and what each company keeps, and the suppliers and customers both name

PRAXPraxis Precision Medicines, Inc.

Mkt capRevenueRevenue

IDYAIDEAYA Biosciences, Inc.

Mkt capRevenueRevenue

Compare

PRAXPraxis Precision Medicines, Inc.

IDYAIDEAYA Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PRAX

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.4%▲+15.95%×1.69

Q1 FY26±7.4%▼−0.98%×0.14

Feb 19 '26±7.3%▲+0.81%×0.11

Q3 FY25±12.1%▼−4.14%×0.34

IDYA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±13.6%▼−0.98%×0.07

Q2 FY26±6.7%▲+2.01%×0.30

= impliedPRAX realized, solidIDYA realized, hatchedOne scale, both sides: full bar = 16%× = |realized| ÷ impliedSource: market data

Q1 FY26

±7.8%

▼−0.35%

×0.04

Feb 17 '26±15.4%▲+1.62%×0.10

PRAXPraxis Precision Medicines, Inc.

277.93▲+5.84%· post 281.99

Mkt cap$7.8BRevenue$7MQ4 FY24Revenue$9MFY24

IDYAIDEAYA Biosciences, Inc.

31.24▲+1.91%· post 31.24

ClosedNov 6 '26

Mkt cap$3.0BRevenue$10MQ3 FY26Revenue—

Compare

ClosedNov 6 '26

PRAXPraxis Precision Medicines, Inc.

IDYAIDEAYA Biosciences, Inc.

277.93▲+5.84%post 281.99

Price

31.24▲+1.91%post 31.24

$7.8B

Mkt cap

$3.0B

Q4 FY24$7M

Revenue

$10MQ3 FY26

FY24$9M

Revenue

—

PRAX277.93▲+5.84%vsIDYA31.24▲+1.91%ClosedNov 6 '26